Trially CEO Kyle McAllister explains why transparent AI reasoning is essential for trial patient matching.
|Articles|April 1, 2007
- Applied Clinical Trials-04-01-2007
- Volume 0
- Issue 0
eShowcase: Oracle Remote Data Capture Onsite
New data entry interface runs on top of existing software for accelerated navigation
Advertisement
New data entry interface runs on top of existing software for accelerated navigation
Oracle Corp. (Redwood Shores, CA) introduced Remote Data Capture Onsite, its next-generation EDC system data collection for clinical trial investigative sites. The interface is designed to accelerate and simplify the collection of clinical data and EDC deployment at investigative sites.
The new Oracle interface runs on top of its existing software product Oracle Remote Data Capture v4.5.1 for more intuitive data entry and navigation of CRFs. The interface allows site personnel to easily locate and update patient information and data entry, as well as add pages to the CRF. The system performs immediate online edit checks, which involves a discrepancy management module from the CRF to capture, route, and resolve discrepancies if applicable.
The Onsite interface features graphic icons that illustrate the status of CRF data. It also enables electronic messaging between users, CRF verifications as a group or individually, and backup approvals with e-signatures.
Oracle Corp., (650) 506-8920,
Articles in this issue
over 19 years ago
Clinical Trial Opportunities in Chinaover 19 years ago
Mission Possible: Rebranding Clinical Researchover 19 years ago
Investigators as Suppliersover 19 years ago
The UK Debate over Recruitment Strategiesover 19 years ago
Creating a Successful Central Metrics Groupover 19 years ago
eShowcase: ISI Solutions Platformover 19 years ago
eShowcase: Velos eResearch Version 7over 19 years ago
EU Approach to Safety: Vox Populi or Vox Dei?over 19 years ago
Industry Trials Poised to Win Back Academiaover 19 years ago
Adapt to Adaptive DesignsAdvertisement
Related to this article
Trially Co-founder and CEO Kyle McAllister, explains how AI absorbing the bulk of clinical-trial chart reviews can free research sites to focus staff time on higher-value tasks.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the shift from narrow AI tools to a continuous learning clinical operating system is where the real operational value lies—and what it takes to get there.
In this Q&A, Saamir Pasha and Carole Berini, PhD, of Ontada discuss what it takes to harmonize fragmented oncology data into reliable real-world evidence, how lab markers can proxy for missing functional status data, and where the biggest remaining barriers to consistent RWE generation lie.
In today’s ACT Brief, we examine who decides what trials measure, how designing for human thinking improves site execution, and how the FDA extended an immunotherapy to a new bladder cancer population.
Clinical trial endpoints define what success looks like, but patients and caregivers are rarely the ones setting that definition, and the gap between what trials measure and what patients actually value is showing up in post-approval evidence, regulatory submissions, and the design rooms where protocols are written.
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.
In today’s ACT Brief, we examine what it will take to scale EHR-to-EDC connections for real-time trials, how the FDA is reimagining rare disease drug development, and why oncology real-world evidence still faces persistent data barriers.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
2
FDA Launches Rare Disease Framework Initiative to Reimagine Drug Development for Small Patient Populations
3
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
4
What It Actually Means to Embed AI Across the Clinical Operating Model
5